Literature DB >> 33271553

Downregulation of miRNA-451a Promotes the Differentiation of CD4+ T Cells towards Th2 Cells by Upregulating ETS1 in Childhood Asthma.

Tianyue Wang1, Qianlan Zhou1, Yunxiao Shang2.   

Abstract

Children exposed to common aeroallergens may develop asthma that progresses into adulthood. Inflammation regulated by T helper 2 (Th2) cells, a specific subpopulation of CD4+ T lymphocytes, is involved in asthmatic injury. Herein, our microarray data indicated that microRNA-451a-5p (miRNA-451a) expression decreased by 4.6-fold and ETS proto-oncogene 1 (ETS1) increased by 2.2-fold in the peripheral blood lymphocytes isolated from asthmatic children (n = 4) as compared to control individuals (n = 4). The negative correlation between miRNA-451a and ETS1 was further validated in 40 CD4+ T cell samples (10 healthy vs. 30 asthmatic samples). In vitro, naïve CD4+ T cells isolated from control individuals were cultured under Th2 cell polarizing condition. miRNA-451a expression decreased while ETS1 increased in CD4+ T cells in the setting of Th2 cell polarization. Moreover, miRNA-451a knockdown enhanced Th2 cell polarization - cells positive for both GATA3 (GATA binding protein 3, a Th2-transcription factor) and CD4 increased, and the generation of Th2 cell cytokines, interleukin (IL)5 and IL13, increased. In contrast, miRNA-451a overexpression inhibited Th2 cell differentiation. Interestingly, dual-Luciferase assay proved ETS1 as a novel target of miRNA-451a. Moreover, enforced expression of ETS1 partially restored miRNA-451a-induced inhibition of IL5 and IL13, and increased the GATA3+CD4+ cell population. Collectively, our work demonstrates that downregulation of miRNA-451a upregulates ETS1 expression in CD4+ T cells, which may contribute to Th2 cell differentiation in pediatric asthma.
© 2020 The Author(s) Published by S. Karger AG, Basel.

Entities:  

Keywords:  Childhood asthma; ETS proto-oncogene 1; Th2 cell differentiation; Type 2 inflammation; miRNA-451a

Year:  2020        PMID: 33271553      PMCID: PMC7879255          DOI: 10.1159/000509714

Source DB:  PubMed          Journal:  J Innate Immun        ISSN: 1662-811X            Impact factor:   7.349


  27 in total

Review 1.  Asthma phenotypes: the evolution from clinical to molecular approaches.

Authors:  Sally E Wenzel
Journal:  Nat Med       Date:  2012-05-04       Impact factor: 53.440

Review 2.  Innate and adaptive immune responses in asthma.

Authors:  Stephen T Holgate
Journal:  Nat Med       Date:  2012-05-04       Impact factor: 53.440

Review 3.  Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease.

Authors:  Gary P Anderson
Journal:  Lancet       Date:  2008-09-20       Impact factor: 79.321

4.  A role for mitogen-activated protein kinase and Ets-1 in the induction of interleukin-10 transcription by human immunodeficiency virus-1 Tat.

Authors:  James C B Li; Allan S Y Lau
Journal:  Immunology       Date:  2007-03-22       Impact factor: 7.397

5.  Asthma and allergic inflammation.

Authors:  Richard M Locksley
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

6.  Increased numbers of activated group 2 innate lymphoid cells in the airways of patients with severe asthma and persistent airway eosinophilia.

Authors:  Steven G Smith; Ruchong Chen; Melanie Kjarsgaard; Chynna Huang; John-Paul Oliveria; Paul M O'Byrne; Gail M Gauvreau; Louis-Philippe Boulet; Catherine Lemiere; James Martin; Parameswaran Nair; Roma Sehmi
Journal:  J Allergy Clin Immunol       Date:  2015-07-17       Impact factor: 10.793

7.  MicroRNA-155 is essential for T(H)2-mediated allergen-induced eosinophilic inflammation in the lung.

Authors:  Carina Malmhäll; Sahar Alawieh; You Lu; Margareta Sjöstrand; Apostolos Bossios; Maria Eldh; Madeleine Rådinger
Journal:  J Allergy Clin Immunol       Date:  2013-12-24       Impact factor: 10.793

Review 8.  Anti-IL5 therapies for asthma.

Authors:  Hugo A Farne; Amanda Wilson; Colin Powell; Lynne Bax; Stephen J Milan
Journal:  Cochrane Database Syst Rev       Date:  2017-09-21

9.  Resveratrol Attenuates Allergic Asthma and Associated Inflammation in the Lungs Through Regulation of miRNA-34a That Targets FoxP3 in Mice.

Authors:  Esraah Alharris; Hasan Alghetaa; Ratanesh Seth; Saurabh Chatterjee; Narendra P Singh; Mitzi Nagarkatti; Prakash Nagarkatti
Journal:  Front Immunol       Date:  2018-12-20       Impact factor: 7.561

10.  The ETS1 transcription factor is required for the development and cytokine-induced expansion of ILC2.

Authors:  Erin C Zook; Kevin Ramirez; Xiaohuan Guo; Grant van der Voort; Mikael Sigvardsson; Eric C Svensson; Yang-Xin Fu; Barbara L Kee
Journal:  J Exp Med       Date:  2016-04-11       Impact factor: 14.307

View more
  3 in total

1.  Skeletons in the Cupboard of Dysfunctional Neutrophils Revealed.

Authors:  Heiko Herwald; Arne Egesten
Journal:  J Innate Immun       Date:  2021-01-21       Impact factor: 7.349

2.  Deficiency of leukocyte-specific protein 1 (LSP1) alleviates asthmatic inflammation in a mouse model.

Authors:  Nguyen Phuong Khanh Le; Amanda Florentina do Nascimento; David Schneberger; Chi Cuong Quach; Xiaobei Zhang; Gurpreet K Aulakh; Wojciech Dawicki; Lixin Liu; John R Gordon; Baljit Singh
Journal:  Respir Res       Date:  2022-06-22

3.  Promotor Hypomethylation Mediated Upregulation of miR-23b-3p Targets PTEN to Promote Bronchial Epithelial-Mesenchymal Transition in Chronic Asthma.

Authors:  Yimin Guo; Xiaoqing Yuan; Luna Hong; Qiujie Wang; Shanying Liu; Zhaolin Li; Linjie Huang; Shanping Jiang; Jianting Shi
Journal:  Front Immunol       Date:  2022-01-04       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.